GoodRx Holdings, Inc.

NASDAQ:GDRX

Medical - Healthcare Information Services

Healthcare
$3.36 +1.72%

+$0.05 today

Market cap
$1.15B
Beta
1.61
P/E (TTM)
44.0
EPS (TTM)
$0.06
52W Low $1.77High $5.81

Volume 0.66M

Average 1.61M

GDRX Acquisitions (Net)

Cash paid for acquiring businesses, net of cash acquired.

GoodRx Holdings, Inc.NASDAQ: GDRX

Acquisitions (Net) · Q1 FY2026 · quarter ended Mar 2026

Acquisitions (net) turns positive

Q1 FY2026 acquisitions (net) was $0, compared with -$30M a year earlier. Trailing-twelve-month acquisitions (net) was $0. Over 3 fiscal years it compounded at -42.2% a year.

Context

  • Acquisitions (net) amounted to 3.8% of revenue in FY2025, up 3.8 pp from a year earlier.
  • Acquisitions (net) increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly acquisitions (net) holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
-$30M— YoY
LTMMar 2026
$0+100.0% YoY
Acquisitions (Net) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+100.0%——
1 year———
3-year CAGR-42.2%——
5-year CAGR——
10-year CAGR——

Acquisitions (Net) history

USD · from the cash flow

Latest · FY2025
(30M) USD
Year-over-year change
—

Acquisitions (Net) vs competitors

How GDRX compares with its peers on the latest reported figures

  • GDRX's LTM Mar 2026 acquisitions (net) of $0 is the 3rd largest of the 4 companies compared; the peer median is $2.08M.
  • Its year-over-year change of +100.0% is the highest of 3, against a peer median of -26.0%.
  • Acquisitions (net) amounts to 0.0% of revenue for GDRX, versus a peer median of 0.7%.
GDRX Competitors Peer median
Acquisitions (Net) for GDRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TDOCTeladoc Health, Inc.LTM Mar 2026$17.3M -73.2%—0.7%
AMWLAmerican Well CorporationLTM Mar 2026$2.08M +21.2%—0.9%
GDRXGoodRx Holdings, Inc.LTM Mar 2026$0 +100.0%-42.2%0.0%
LFMDLifeMD, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding GDRX) $2.08M-26.0%—0.7%

Competitors are the stored peer set for GDRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(25.25M)(32.83M)(8.87M)16.39M30.44M
Depreciation & Amortization34.54M54.18M111.77M69.54M85.22M
Deferred Income Tax12.85M(497K)(65.56M)(11.91M)20.07M
Stock-Based Compensation160.46M120.23M104.82M99.03M76.63M
Change in Working Capital(11.8M)(20.29M)(21.94M)2.09M(56.44M)
Accounts Receivables(43.95M)1.38M(26.47M)(2.33M)(88.02M)
Inventory00000
Accounts Payables4.21M(874K)17.46M(21.24M)4.1M
Other Working Capital27.95M(20.79M)(12.93M)25.66M27.47M
Other Non-Cash Items7.98M25.98M18.07M8.76M11.99M
Operating Cash Flow178.78M146.78M138.29M183.89M167.9M
Capital Expenditures(34.46M)(55.21M)(55.77M)(70.35M)(3.52M)
Acquisitions (Net)(144.28M)(155.28M)00(30M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(29.89M)(51.25M)(54.72M)(70.35M)(87.68M)
Investing Cash Flow(178.73M)(210.5M)(55.77M)(70.35M)(119.96M)
Debt Repayment(7.03M)(7.03M)(5.27M)(167.01M)(3.75M)
Common Stock Issued00000
Common Stock Repurchased0(101.72M)(103.97M)(158.85M)(206.94M)
Dividends Paid00000
Other Financing Activities(23.5M)(11.48M)(58.15M)(11.65M)(23.78M)
Financing Cash Flow(30.53M)(120.23M)(167.4M)(337.5M)(234.47M)
Effect of Forex Changes00000
Net Change in Cash(30.48M)(183.94M)(84.87M)(223.95M)(186.53M)
Free Cash Flow144.32M91.57M82.53M113.55M164.38M

GoodRx Holdings, Inc.

NASDAQ:GDRX

Intrinsic Alpha fair value

Locked

Current Price

$3.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.